We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
From Apr 2019 to Apr 2024
GlaxoSmithKline Pharmaceuticals Ltd. (500660.BY) Tuesday said first-quarter net profit rose 13% to INR1.61 billion from INR1.43 billion a year earlier, beating analysts' estimates.
The Indian unit of GlaxoSmithKline PLC (GSK.LN) said net sales in the three months ended March 31 rose 18% to INR5.41 billion from INR4.57 billion.
A Dow Jones Newswires poll of seven analysts had expected a net profit of INR1.42 billion on net sales of INR5.22 billion.
The company didn't immediately provide a reason for the rise in earnings.
By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; rumman.ahmed@dowjones.com
Order free Annual Report for GlaxoSmithKline plc
Visit http://djnweurope.ar.wilink.com/?ticker=GB0009252882 or call +44 (0)208 391 6028
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
